Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
Latest Information Update: 21 Jul 2022
At a glance
- Drugs Filgrastim (Primary)
- Indications Biliary atresia
- Focus Adverse reactions
- Acronyms BA_GCSF
- 22 Jul 2021 New trial record
- 01 Jul 2021 Results assessing safety and efficacy of Granulocyte-colony stimulating factor (Neupogen) in Kasai patients with biliary atresia, published in the Journal of Pediatric Surgery.